Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1079/bjn19970191

http://scihub22266oqcxt.onion/10.1079/bjn19970191
suck pdf from google scholar
9389897!?!9389897

suck abstract from ncbi

pmid9389897      Br+J+Nutr 1997 ; 78 (5): 737-50
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects #MMPMID9389897
  • Itoh K; Kawasaka T; Nakamura M
  • Br J Nutr 1997[Nov]; 78 (5): 737-50 PMID9389897show ga
  • In a double-blind, placebo-controlled study, thirty-three subjects were allocated to undergo either a 4-week treatment with oral Mg supplementation (Mg(OH)2; 411-548 mg Mg/d) or a placebo. The urinary excretion of Mg increased significantly in both the first 2 weeks and the following 2 weeks of Mg supplementation, while the urinary Na excretion also increased significantly over the experimental period. The systolic and diastolic blood pressure values decreased significantly in the Mg group, but not in the placebo group. The urinary aldosterone excretion and packed cell volume increased significantly during the last 2 weeks of the experimental period compared with the run-in period and first 2 weeks of supplementation. There was a statistically significant positive correlation between the values for urinary noradrenaline excretion and diastolic blood pressure at the end of the supplementation period (both expressed as a percentage of the run-in value). Statistically significant increases in lecithin-cholesterol acyltransferase (EC 2.3.1.43; LCAT), HDL-cholesterol and apolipoprotein AI were also observed after Mg supplementation. A significant positive correlation was observed between the levels of LCAT and urinary Mg excretion for the experimental period (expressed as a percentage of the run-in value). The total cholesterol:HDL-cholesterol ratio decreased significantly during the last 2 weeks of Mg supplementation compared with the first 2 weeks and the run-in periods, but this did not occur in the placebo group. These results suggest that Mg supplementation may lower blood pressure through the suppression of the adrenergic activity and possible natriuresis, while also improving the serum lipids through the activation of LCAT in human subjects.
  • |Administration, Oral[MESH]
  • |Aged[MESH]
  • |Aldosterone/urine[MESH]
  • |Apolipoprotein A-I/metabolism[MESH]
  • |Blood Pressure/*drug effects[MESH]
  • |Cholesterol, HDL/blood[MESH]
  • |Cholesterol/blood[MESH]
  • |Diastole[MESH]
  • |Double-Blind Method[MESH]
  • |Enzyme Activation/drug effects[MESH]
  • |Female[MESH]
  • |Hematocrit[MESH]
  • |Humans[MESH]
  • |Lipids/*blood[MESH]
  • |Magnesium/*administration & dosage/urine[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Norepinephrine/urine[MESH]
  • |Phosphatidylcholine-Sterol O-Acyltransferase/blood[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box